News

Oxford Brain Diagnostics releases Beta version software tool to interpret MRI images for brain degradation analysis (FDA breakthrough device designation)

Published on: 26/07/2021

Oxford Brain Diagnostics releases Beta version software tool to interpret MRI images for brain degradation analysis (FDA breakthrough device designation)
Member News

Oxford Brain Diagnostics is currently developing a new software tool (beta version) for the interpretation of MRI images, pulling together current methods (like brain atrophy) with a new measure that analyses brain degradation at a cellular level. 

The company is looking for clinicians (neurologists, old age psychiatrists, radiologists) interested in learning about this novel way of diagnosis that can predict transition from MCI to Alzheimer’s Disease, and has received FDA breakthrough device designation. 

Discover More

Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford Brain Diagnostics is committed to assessing brain health based on changes in the cellular structure, supporting drug development, and helping clinicians around the world in their fight to defeat Alzheimer’s and other neurodegenerative diseases.

For more information please contact Daniel Kaute, Daniel.kaute@oxfordbraindiagnostics.com

NEWS​

Related News

Open call of 40k for up to 6-Month VR/AR Co-Creation with Leading European SMEs

13 May 2025
The VR Health Champions project, coordinated by Instituto Pedro Nunes (IPN), has launched an Open Call offering up to €40,000 to SMEs developing innov...

Toronto’s new innovation studio highlights aging-in-place solutions

13 May 2025
Located in the heart of downtown Toronto, the AGE-WELL Innovation Studio is your gateway to the future of aging and care. Whether you’re a tech compan...

Society for Women’s Health Research: advancing women’s health through science, policy, and education

13 May 2025
Founded in 1990 by a group of physicians, medical researchers, and health advocates, SWHR is making women’s health mainstream by addressing unmet need...

VUGENE secures 1 million Euros to revolutionize biological research

7 May 2025
VUGENE, a Lithuania-based multi-omics data analysis company, has announced the closing an investment round of €1 million, led by Superhero Capital tog...

AMR EDUCare: Empowering europe’s healthcare professionals to tackle antimicrobial resistance

6 May 2025

Connect, Innovate, and Transform Healthcare at the AHB Symposium 2025

6 May 2025

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *